曲唑酮:修订间差异
外观
删除的内容 添加的内容
第23行: | 第23行: | ||
| bioavailability = [[口服给药]]: 65%<ref name="DrugPoint">Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Oct 1]. Greenwood Village, CO: Thomsen Healthcare; 2013. {{Failed verification|date=April 2017|reason=search for "Trazodone" fails on Truven Web site}}</ref> |
| bioavailability = [[口服给药]]: 65%<ref name="DrugPoint">Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Oct 1]. Greenwood Village, CO: Thomsen Healthcare; 2013. {{Failed verification|date=April 2017|reason=search for "Trazodone" fails on Truven Web site}}</ref> |
||
| protein_bound = 89–95%<ref>{{cite web|url=http://www.drugbank.ca/drugs/DB00656| title=Trazodone|website=DrugBank|accessdate=7 June 2015}}</ref> |
| protein_bound = 89–95%<ref>{{cite web|url=http://www.drugbank.ca/drugs/DB00656| title=Trazodone|website=DrugBank|accessdate=7 June 2015}}</ref> |
||
| metabolism = [[肝臟 |
| metabolism = [[肝臟]]([[CYP3A4]])<ref>{{cite book |last1=Lemke |first1=Thomas L. |last2=Williams |first2=David A. |title=Foye's Principles of Medicinal Chemistry |date=2012 |publisher=Lippincott Williams & Wilkins |isbn=9781609133450 |page=615 |url=https://books.google.ca/books?id=Sd6ot9ul-bUC&pg=PA615 |language=en}}</ref> |
||
| metabolites = {{abbrlink|mCPP|meta-Chlorophenylpiperazine}}<ref name="PreskornStanga2012">{{cite book|author1=Sheldon H. Preskorn|author2=Christina Y. Stanga|author3=John P. Feighner|author4=Ruth Ross|title=Antidepressants: Past, Present and Future|url=https://books.google.com/books?id=Ue3uCAAAQBAJ&pg=PA68|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-18500-7|pages=68–}}</ref> |
| metabolites = {{abbrlink|mCPP|meta-Chlorophenylpiperazine}}<ref name="PreskornStanga2012">{{cite book|author1=Sheldon H. Preskorn|author2=Christina Y. Stanga|author3=John P. Feighner|author4=Ruth Ross|title=Antidepressants: Past, Present and Future|url=https://books.google.com/books?id=Ue3uCAAAQBAJ&pg=PA68|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-3-642-18500-7|pages=68–}}</ref> |
||
| onset = [[口服给药|By mouth]]: 1 hour ({{tsl|en|Tmax (pharmacology)||{{abbr|T<sub>max</sub>|Time to peak concentrations}}}})<ref>{{cite web |url=http://www.pharmacychoice.com/mdx/drugpoint.cfm?docID=622860&letter=T&type=Generic%20Name |title=MicroMedex DrugPoints - Trazodone|website=Pharmacy Choice|date= |author= |accessdate= 20 April 2017}}</ref> |
| onset = [[口服给药|By mouth]]: 1 hour ({{tsl|en|Tmax (pharmacology)||{{abbr|T<sub>max</sub>|Time to peak concentrations}}}})<ref>{{cite web |url=http://www.pharmacychoice.com/mdx/drugpoint.cfm?docID=622860&letter=T&type=Generic%20Name |title=MicroMedex DrugPoints - Trazodone|website=Pharmacy Choice|date= |author= |accessdate= 20 April 2017}}</ref> |
||
第79行: | 第79行: | ||
{{镇痛药}} |
{{镇痛药}} |
||
{{Hypnotics_and_sedatives}} |
{{Hypnotics_and_sedatives}} |
||
{{藥學小作品}} |
|||
[[Category:血清素受体激动剂]] |
[[Category:血清素受体激动剂]] |
||
[[Category:血清素拮抗剂]] |
[[Category:血清素拮抗剂]] |
2019年2月25日 (一) 15:20的版本
臨床資料 | |
---|---|
商品名 | Many brand names worldwide[1] |
其他名稱 | AF-1161 |
AHFS/Drugs.com | Monograph |
MedlinePlus | a681038 |
给药途径 | By mouth (tablets) |
ATC碼 | |
法律規範狀態 | |
法律規範 |
|
藥物動力學數據 | |
生物利用度 | 口服给药: 65%[2] |
血漿蛋白結合率 | 89–95%[3] |
药物代谢 | 肝臟(CYP3A4)[7] |
代謝產物 | mCPP[4] |
藥效起始時間 | By mouth: 1 hour (Tmax)[5] |
生物半衰期 | Trazodone IR: 7 hours[2] Trazodone ER: 10 hours[2] mCPP: 4–8 hours[6] |
排泄途徑 | 尿:70–75%[2] 糞便:21%[2] |
识别信息 | |
| |
CAS号 | 19794-93-5 |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.039.364 |
化学信息 | |
化学式 | C19H22ClN5O |
摩尔质量 | 371.8641 g/mol |
3D模型(JSmol) | |
| |
|
曲唑酮(英語:Trazodone)是一種口服抗抑鬱藥.[8],用來治療重性抑鬱障礙、焦慮症,也配合其他藥品來治療酒精依賴[8]。Trazodone以多種商品名行銷於世界各地[1]。
常見的副作用包含口乾、頭昏、嘔吐和頭痛[8],較為嚴重的副作用為:自殺、躁狂導致之雙極性精神症狀、心律不整、陰莖異常勃起[8]。目前還不清楚在懷孕或哺乳期間使用是否安全[9]。該藥物品屬於苯基哌嗪(phenylpiperazine)類藥物,為一種血清素拮抗劑和再攝取抑制劑(SARI)[10][11],Trazodone還具有鎮靜的副作用[12]。
該藥品於1981年在美國批准用於醫療用途[8],現已有通用名藥物上市[8]。截至2019年,每月劑量在英國公醫(NHS)的採購藥價約7.46英鎊[13]。2018年,美國的每月劑量批發價約4.53美元[14]。2016年,它是美國第24大處方用藥,單年處方超過2500萬筆 [15]。
是一種抗抑郁药,用來治療重性抑郁障碍、焦虑症、酒精依賴或其他療程的輔助藥品。Trazodone以多種商品名行銷於世界各地。[1][8]
Trazodone常見的副作用包含口乾、頭暈、呕吐和頭痛。較為嚴重的副作用為:自殺、躁鬱症、心律不整、陰莖異常勃起。[8]
文獻來源
- ^ 1.0 1.1 1.2 Drugs.com international listings for Trazodone Page accessed Feb 10, 2016
- ^ 2.0 2.1 2.2 2.3 2.4 Truven Health Analytics, Inc. DrugPoint System (Internet) [cited 2013 Oct 1]. Greenwood Village, CO: Thomsen Healthcare; 2013. [與來源不符]
- ^ Trazodone. DrugBank. [7 June 2015].
- ^ Sheldon H. Preskorn; Christina Y. Stanga; John P. Feighner; Ruth Ross. Antidepressants: Past, Present and Future. Springer Science & Business Media. 6 December 2012: 68–. ISBN 978-3-642-18500-7.
- ^ MicroMedex DrugPoints - Trazodone. Pharmacy Choice. [20 April 2017].
- ^ Alan F. Schatzberg, M.D.; Charles B. Nemeroff, M.D., Ph.D. The American Psychiatric Association Publishing Textbook of Psychopharmacology, Fifth Edition. American Psychiatric Pub. 2017: 460–. ISBN 978-1-58562-523-9.
- ^ Lemke, Thomas L.; Williams, David A. Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. 2012: 615. ISBN 9781609133450 (英语).
- ^ 8.0 8.1 8.2 8.3 8.4 8.5 8.6 8.7 Trazodone Hydrochloride. The American Society of Health-System Pharmacists. [8 January 2018].
- ^ Trazodone Use During Pregnancy. Drugs.com. [7 January 2018].
- ^ Stahl, Stephen M. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. Cambridge University Press. 2008: 567. ISBN 9780521857024 (英语).
- ^ Lemke, Thomas L.; Williams, David A. Foye's Principles of Medicinal Chemistry. Lippincott Williams & Wilkins. 2008: 586. ISBN 9780781768795 (英语).
- ^ British national formulary : BNF 69 69. British Medical Association. 2015: 257–258. ISBN 9780857111562.
- ^ British national formulary : BNF 76 76. Pharmaceutical Press. 2018: 367. ISBN 9780857113382.
- ^ NADAC as of 2018-01-03. Centers for Medicare and Medicaid Services. [7 January 2018] (英语).
- ^ The Top 300 of 2019. clincalc.com. [22 December 2018].